Childhood Lymphomas: Resources
This page is dedicated to listing many childhood lymphoma resources, including information on diagnosis, staging, cancer types, and treatments. This information is geared toward children. If you know of any childhood resources that are not listed on this website, please e-mail us.
Resources on Lymphomainfo.net
The following are the most common lymphomas to affect children:
Other Resources
- Childhood Lymphomas on Lymphomation.org
- Kid’s Health
- National Cancer Institute’s Childhood Hodgkin’s
- National Cancer Institute’s Childhood Non-Hodgkin’s
- AIDS Related Lymphomas
- Childhood Lymphomas Information Guide
- The National Childhood Cancer Foundation has facts on the incidence of childhood lymphoma
- Article on Childhood Lymphomas by Dr. Faith Kung for Cancer News on the Net
- Childhood Non-Hodgkin's Lymphoma Resources - Children's Cancer Web
- Childhood Hodgkin's Disease Resources - Children's Cancer Web
- NCI can also be contacted via telephone at (800) 4-CANCER. See their web site for other contact information.
Related Articles
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
